IDEAYA BIOSCIENCES INC (IDYA)
US45166A1025 - Common Stock
ChartMill assigns a Buy % Consensus number of 89% to IDYA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 53.96. This target is 35.81% above the current price.
IDYA was analyzed by 17 analysts. The buy percentage consensus is at 89. So analysts seem to be very confident about IDYA.
In the previous month the buy percentage consensus was at a similar level.
IDYA was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-21 | Citigroup | Maintains | Buy -> Buy |
| 2024-03-08 | BTIG | Initiate | Buy |
| 2024-02-23 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-02-21 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-01-26 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-01-25 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-01-10 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-12-06 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-11-30 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-11-13 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-11-08 | Guggenheim | Maintains | Buy -> Buy |
| 2023-11-08 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-10-24 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-10-11 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-09-12 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-09-12 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-08-17 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-08-11 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-08-11 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-08-11 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-08-08 | SVB Leerink | Initiate | Outperform |
| 2023-05-24 | Goldman Sachs | Initiate | Buy |
| 2023-04-24 | Guggenheim | Maintains | Buy |
| 2023-04-24 | Stifel | Upgrade | Hold -> Buy |
| 2023-03-23 | Berenberg | Initiate | Buy |
| 2023-03-08 | Guggenheim | Reiterate | Buy |
| 2023-03-08 | RBC Capital | Reiterate | Outperform |
| 2023-02-28 | RBC Capital | Initiate | Outperform |
| 2022-12-28 | Capital One | Initiate | Overweight |
| 2022-11-18 | Baird | Maintains | Outperform |